@entity2436 has been described in @entity1 with @entity717 ( @entity717 ). These are the first three published cases of @entity2436 in adults older than 50 years of age with @entity717 . They were followed using the KANNER scale and, in one case, @entity1011 phosphokinase (CPK) monitoring. Case 1 is a 67-year-old Caucasian who probably had been having intermittent episodes of undiagnosed @entity2436 withdrawal for many years. His episodes of @entity2146 and @entity146 responded to @entity2934 up to 8   mg/day. Case 2 is a 63-year-old Caucasian male who had probably had undiagnosed @entity2437 episodes since age 25. An @entity2146 episode that rated 88 on Part 2 of the KANNER scale ended within minutes after he received 1   mg of intramuscular @entity2934 . He had no symptom relapses for 4 years after getting stable oral @entity2934 doses (3-8.5   mg/day). Case 3 is a 55-year-old African-American male with severe @entity25878 and @entity1168 (with a pacemaker). He had been "institutionalized" since age 22 and his undiagnosed @entity2437 episodes appeared to have been intermittently present for at least the last ten years. As he became tolerant and experienced symptom relapse, oral @entity2934 was slowly increased (1.5-18   mg/day). Electroconvulsive therapy was ruled out due to his pacemaker.

@entity2436 in Older Adult Individuals with XXXX .

@entity1 :: ('9606', 'Species') :: ['children'] @entity717 :: ('MESH:D009069', 'Disease') :: ['IDs', 'intellectual disabilities'] @entity146 :: ('MESH:D001523', 'Disease') :: ['withdrawal behavior'] @entity1168 :: ('MESH:D001919', 'Disease') :: ['bradycardia'] @entity25878 :: ('MESH:C537985', 'Disease') :: ['ID'] @entity2146 :: ('MESH:D011595', 'Disease') :: ['agitation'] @entity1011 :: ('MESH:D003404', 'Chemical') :: ['creatinine'] @entity2436 :: ('MESH:D002389', 'Disease') :: ['Catatonia', 'catatonia'] @entity2437 :: ('MESH:D012560', 'Disease') :: ['catatonic'] @entity2934 :: ('MESH:D008140', 'Chemical') :: ['lorazepam']
@entity717 :: (MESH:D009069,Disease) :: ['Intellectual Disabilities']
